Are You at Risk?Prostate Health AssessmentTips for Talking to Your Doctor

Text Size  

Prostate Health Assessment (PHA)

Only your health care provider can tell if you have Enlarging Prostate and not a more serious condition, such as prostate cancer. But you can help by taking the Prostate Health Assessment today. Once completed, the findings can help you prepare for talking with your doctor about the health of your prostate.

Take the Prostate Health Assessment now.

*Indicates required field.
 

Please check one.

*Please indicate whether you're responding on behalf of yourself or a loved one. If for a loved one, please answer on their behalf. (check one)

 Self   Loved one

Thank you for your interest in the Prostate Health Assessment. According to the answers you provided, you are a female answering the assessment on behalf of yourself. It is important to note that Enlarging Prostate is a disease that only affects men. If you are completing the Prostate Health Assessment for a male loved one, we welcome you to go back and check the box next to 'Loved one' in question #1. To exit the the Prostate Health Assessment and return to the homepage, CLICK HERE.

Please check one.

*What gender are you? (check one)

 Male   Female

Please check one.

*Is your PSA level 1.5 ng/mL or greater? (check one)

 Yes   No   Don't know

Please check all that apply.

*Are you currently experiencing any of the following urinary symptoms? (check all that apply)

 Feeling the urge to go all the time
 Frequently waking up at night to go
    Trouble starting and stopping
    Other    None of the above

Please check one.

*Has a doctor or health care provider ever told you that you have Enlarging Prostate (EP), or benign prostatic hyperplasia (BPH)? (check one)

 Yes   No

Please check all that apply.

*Are you currently taking a prescription medication or herbal remedy to treat Enlarging Prostate? (check all that apply)

 AVODART® (dutasteride)
 Proscar® (finasteride)
   Flomax® (tamsulosin HCl)
   Other   Not currently taking anything for EP

Please enter your first name.

*First Name:

Please enter your last name.

*Last Name:

Please enter your address.

*Address:

Please enter your city.

*City:

Please enter your state.

*State:

Please enter your ZIP Code.

*ZIP Code:

Please enter/format your e-mail address
(eg, name@company.com).

*E-mail Address:

Please enter your year of birth.

*Year of Birth:

Race: (optional)


By providing your name, address, e-mail address and other information, you are giving GlaxoSmithKline (GSK) and companies working with GSK permission to market or advertise to you regarding the medical condition(s) in which you have expressed interest, as well as other general health-related information from GSK. GSK will not sell or transfer your name, address, or e-mail address to any other party for their own marketing use.

If you prefer not to be contacted or receive future communications, please call 1-888-825-5249.

AVODART is a registered trademark of GlaxoSmithKline.
Flomax is a registered trademark of Boehringer Ingelheim Pharmaceuticals, Inc.
Proscar is a registered trademark of Merck & Co., Inc.


Indication and Important Safety Information About AVODART® (dutasteride):

AVODART is used to treat urinary symptoms of Enlarging Prostate, and to reduce the risk of acute urinary retention (AUR) and prostate surgery. AUR is a condition, possibly requiring surgery, where the prostate is so enlarged that it completely blocks urine coming from the bladder. Only your health care provider can tell if your symptoms are from Enlarging Prostate and not a more serious condition, such as prostate cancer. See your doctor for regular exams. Women and children should not take AVODART. Women who are or could become pregnant should not handle AVODART due to the potential risk of a specific birth defect. Do not donate blood until at least 6 months after stopping AVODART. Tell your doctor if you have liver disease. AVODART may not be right for you. Possible side effects, including sexual side effects and swelling or tenderness of the breast, occur infrequently. While some men have fewer problems and symptoms after 3 months of treatment with AVODART, a treatment period of at least 6 months is usually necessary to see if AVODART will work for you.
 

Click here for complete Prescribing Information for AVODART Soft Gelatin Capsules, 0.5 mg
 

Complete Prescribing Information for AVODART Soft Gelatin Capsules, 0.5 mg, is provided in Adobe's Portable Document Format (PDF). To view these documents you will need Adobe Acrobat Reader; if you do not have it, follow the link to download a copy.
 

If you are unable to or do not wish to download Acrobat Reader, but still wish to receive complete Prescribing Information, please click here.

GSK Corporation        GSK For You        Contact Us

This site is intended for US residents only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us